Global market

Brexit’s Uncertainty Principle

While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...

Outlook: Medtech 2030

Having travelled in Europe in the last few weeks meeting clients and candidates, I wanted to share some reflections with you linked to one...

A Report from BIO-Europe Spring 2017

The blue skies and balmy weather of Barcelona were the perfect backdrop for BIO-Europe Spring this year. The 2,400 biotech pros at the conference...

Report from J.P. Morgan 2017

So, that’s the J.P. Morgan Healthcare Conference done for another year. For just a few highly energised days it felt as if nearly every...

Shaping up for growth in a world of change

The 34th FT Global Pharmaceutical and Biotechnology Conference brought together life science and pharma companies as well as emerging new players. Discussions centered on industry challenges,...